Incyte Corporation (INCY) News Headlines

▮ More

Date

Headline

9/30/2021 6:40:08 AM Lilly, Incyte Present Detailed Results From OLUMIANT BRAVE-AA1, BRAVE-AA2 Trials In Alopecia Areata

9/30/2021 6:03:38 AM Lilly Announces Detailed Results From Two Pivotal Phase 3 Trials Of BRAVE-AA1 And BRAVE-AA2 For Alopecia Areata

9/27/2021 6:19:44 AM Syndax Partners With Incyte To Develop, Commercialize Axatilimab - Quick Facts

9/27/2021 6:02:33 AM Syndax Pharma, Incyte Enters Exclusive Worldwide Collaboration And License Agreement To Develop Axatilimab

9/22/2021 1:01:14 PM Incyte Announces FDA Approval Of Jakafi For Treatment Of Chronic Graft-Versus-Host Disease

9/22/2021 12:11:02 PM Incyte Shares Slip 7% Despite FDA Approving Its Atopic Dermatitis Drug

9/21/2021 11:31:14 PM FDA Approves Incyte's Opzelura Cream To Treat Atopic Dermatitis

9/13/2021 10:45:16 AM Incyte To Present At Morgan Stanley Global Healthcare Conference; Webcast At 11:45 AM ET

8/30/2021 2:43:24 AM Biotech Stocks Facing FDA Decision In September 2021

8/26/2021 11:23:16 PM MorphoSys : EU Conditionally Approves Minjuvi - Lenalidomide To Treat Relapsed Or Refractory DLBCL

8/24/2021 8:44:10 AM Incyte Reports Conditional Approval Of Minjuvi In Canada For Patients With DLBCL

8/24/2021 8:32:19 AM Incyte: Health Canada Approves Minjuvi In Combination With Lenalidomide For R/r Diffuse Large B-Cell Lymphoma

8/17/2021 4:44:48 AM Incyte, InnoCare In Collaboration And License Deal For Tafasitamab In Greater China

8/17/2021 4:23:32 AM Incyte Announces Commercialization Agreement With InnoCare For Tafasitamab In Greater China

8/3/2021 7:32:38 AM Incyte Corporation (INCY) Has Lowered Its FY21 EPS Estimate To 2125 - 2170 From 2125 - 2200

8/3/2021 7:32:33 AM Incyte Corporation Q2 adjusted earnings Beat Estimates

8/3/2021 7:09:28 AM Incyte Q2 GAAP EPS $0.67; Non-GAAP EPS $0.80

8/3/2021 6:36:53 AM Lilly, Incyte: Baricitinib Reduced Deaths In COVID-19 Patients Under Invasive Mechanical Ventilation

8/3/2021 6:05:06 AM Eli Lilly, Incyte Announce Results From Additional Cohort Of 101 Adult Patients From COV-BARRIER Trial

7/29/2021 9:45:21 AM Lilly : FDA Broadens Emergency Use Of Baricitinib In Patients Hospitalized With COVID-19